導(dǎo)師簡(jiǎn)介

姓名：梁超杰性別：男政治面貌：中共黨員學(xué)歷：博士研究生學(xué)位：博士職稱：副教授

博、碩導(dǎo)師：碩士生導(dǎo)師本崗位工作年數(shù)：7年

研究方向：

膽胰外科

榮譽(yù)稱號(hào)：

無

學(xué)術(shù)任職：

中國(guó)醫(yī)促會(huì)腔鏡與內(nèi)鏡分會(huì)委員；中國(guó)中西醫(yī)結(jié)合會(huì)肝膽外科分會(huì)委員；中國(guó)抗癌協(xié)會(huì)營(yíng)養(yǎng)分會(huì)委員

近五年承擔(dān)科研課題情況：

例如：山西省應(yīng)用基礎(chǔ)研究計(jì)劃項(xiàng)目項(xiàng)目名稱：m6A調(diào)控DcR3異常表達(dá)在肝癌發(fā)生發(fā)展中的機(jī)制研究，項(xiàng)目編號(hào): 201901D211480

代表性論著及近五年的代表性論文（限10項(xiàng)以內(nèi)）：

例如：

Liang, Chaowei; Fan, Jiaxin;Liang, Chaojie; Guo, Jiansheng; Identification and Validation of a Pyroptosis-Related Prognostic Model for Gastric Cancer, Frontiers in Genetics, 2022, 12:699503.

Li, Guanqun; Zhang, Dongxin; Liang, Chaowei;Liang, Chaojie; Wu, Jixiang; Construction and validation of a prognostic model of pyroptosis related genes in hepatocellular carcinoma, Frontiers in oncology, 2022, 12:1021775.

Liang, Chaojie; Shan, Dan; Wei, Zhigang; PDO-Based Drug Screening in Advanced Pancreatic Cancer: Addressing Predictive Value and Broader Clinical Implications, Gastroenterology, 2024, 168: 627-636.

Wei, Zhigang; Shan, Dan;Liang, Chaojie; Does MASH comorbidity in CHB truly suppress immune function? Journal of Hepatology, 2024, S0168-8278:02698-9.

Gong, Xiaowen; Xuan, Yuerong; Pang, Chengshuai; Dong, Chenyang; Cao, Rui; Wei, Zhigang;Liang, Chaojie; DUPAN-2 in pancreatic cancer: Systematic review and meta-analysis, Clinica Chimica Acta, 2025, 567: 120080